Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Puberty | 9 | 2024 | 58 | 4.510 |
Why?
|
| Barrett Esophagus | 13 | 2013 | 114 | 2.650 |
Why?
|
| Esophageal Neoplasms | 14 | 2013 | 116 | 2.310 |
Why?
|
| Obesity | 11 | 2022 | 839 | 1.820 |
Why?
|
| Adenocarcinoma | 12 | 2013 | 177 | 1.780 |
Why?
|
| Puberty, Precocious | 2 | 2022 | 8 | 1.570 |
Why?
|
| Body Mass Index | 14 | 2022 | 961 | 1.570 |
Why?
|
| Gastroesophageal Reflux | 11 | 2014 | 79 | 1.560 |
Why?
|
| Pediatric Obesity | 2 | 2022 | 75 | 1.540 |
Why?
|
| Stomach Neoplasms | 6 | 2008 | 42 | 1.300 |
Why?
|
| Diabetes, Gestational | 4 | 2017 | 338 | 1.230 |
Why?
|
| Diet | 5 | 2013 | 359 | 1.190 |
Why?
|
| Cardia | 6 | 2008 | 15 | 1.150 |
Why?
|
| Female | 39 | 2024 | 12838 | 1.150 |
Why?
|
| Humans | 46 | 2024 | 18058 | 1.080 |
Why?
|
| Child | 10 | 2024 | 2519 | 0.980 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2014 | 22 | 0.980 |
Why?
|
| Hepatitis B Vaccines | 2 | 2014 | 46 | 0.960 |
Why?
|
| Hepatitis B | 2 | 2014 | 43 | 0.950 |
Why?
|
| Menarche | 2 | 2022 | 30 | 0.950 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2016 | 144 | 0.920 |
Why?
|
| Male | 30 | 2024 | 10173 | 0.820 |
Why?
|
| Mindfulness | 2 | 2019 | 27 | 0.810 |
Why?
|
| Adolescent | 15 | 2024 | 3714 | 0.780 |
Why?
|
| Risk Factors | 18 | 2019 | 3394 | 0.760 |
Why?
|
| Caregivers | 2 | 2019 | 125 | 0.760 |
Why?
|
| Stress, Psychological | 3 | 2019 | 145 | 0.720 |
Why?
|
| Pregnancy | 7 | 2022 | 1484 | 0.620 |
Why?
|
| Antioxidants | 2 | 2008 | 39 | 0.620 |
Why?
|
| Case-Control Studies | 13 | 2014 | 1164 | 0.610 |
Why?
|
| Breast Feeding | 1 | 2019 | 134 | 0.610 |
Why?
|
| Adult | 24 | 2020 | 7696 | 0.600 |
Why?
|
| Middle Aged | 23 | 2019 | 8073 | 0.590 |
Why?
|
| California | 12 | 2024 | 2327 | 0.580 |
Why?
|
| Dietary Fiber | 3 | 2013 | 59 | 0.530 |
Why?
|
| Precancerous Conditions | 5 | 2013 | 48 | 0.530 |
Why?
|
| Weight Gain | 1 | 2017 | 180 | 0.520 |
Why?
|
| Heartburn | 1 | 2014 | 4 | 0.500 |
Why?
|
| Adiposity | 1 | 2014 | 66 | 0.470 |
Why?
|
| Child, Preschool | 3 | 2024 | 1428 | 0.470 |
Why?
|
| Neoplasms | 1 | 2019 | 464 | 0.460 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2008 | 55 | 0.450 |
Why?
|
| Young Adult | 10 | 2018 | 2479 | 0.450 |
Why?
|
| Feeding Behavior | 1 | 2014 | 165 | 0.450 |
Why?
|
| Quality of Life | 3 | 2019 | 509 | 0.450 |
Why?
|
| Infant, Newborn | 3 | 2022 | 852 | 0.450 |
Why?
|
| Waist Circumference | 1 | 2013 | 37 | 0.440 |
Why?
|
| Prospective Studies | 3 | 2022 | 1294 | 0.440 |
Why?
|
| Surveys and Questionnaires | 7 | 2019 | 1346 | 0.440 |
Why?
|
| Alcohol Drinking | 3 | 2014 | 375 | 0.420 |
Why?
|
| Patient Compliance | 1 | 2014 | 303 | 0.410 |
Why?
|
| Fruit | 2 | 2010 | 72 | 0.410 |
Why?
|
| Vegetables | 2 | 2010 | 80 | 0.410 |
Why?
|
| Life Style | 3 | 2016 | 329 | 0.380 |
Why?
|
| Yoga | 1 | 2011 | 26 | 0.380 |
Why?
|
| Micronutrients | 1 | 2010 | 9 | 0.370 |
Why?
|
| Aged | 17 | 2018 | 6258 | 0.370 |
Why?
|
| Cohort Studies | 4 | 2022 | 2631 | 0.370 |
Why?
|
| Smoking | 2 | 2014 | 465 | 0.360 |
Why?
|
| Meat | 1 | 2009 | 26 | 0.340 |
Why?
|
| Beer | 1 | 2008 | 9 | 0.330 |
Why?
|
| Wine | 1 | 2008 | 18 | 0.330 |
Why?
|
| Dietary Fats | 1 | 2009 | 90 | 0.330 |
Why?
|
| Longitudinal Studies | 4 | 2021 | 705 | 0.300 |
Why?
|
| Feasibility Studies | 3 | 2019 | 116 | 0.300 |
Why?
|
| Age Factors | 4 | 2019 | 945 | 0.290 |
Why?
|
| Continental Population Groups | 3 | 2019 | 317 | 0.280 |
Why?
|
| Transients and Migrants | 1 | 2005 | 2 | 0.270 |
Why?
|
| Mexican Americans | 1 | 2005 | 48 | 0.260 |
Why?
|
| Heart Failure | 1 | 2011 | 391 | 0.260 |
Why?
|
| Risk-Taking | 1 | 2005 | 113 | 0.250 |
Why?
|
| Sexual Maturation | 1 | 2024 | 7 | 0.240 |
Why?
|
| Cross-Sectional Studies | 4 | 2017 | 1309 | 0.240 |
Why?
|
| Hawaii | 1 | 2024 | 45 | 0.240 |
Why?
|
| Incidence | 7 | 2010 | 1297 | 0.240 |
Why?
|
| Proportional Hazards Models | 3 | 2022 | 745 | 0.230 |
Why?
|
| Coffee | 1 | 2003 | 5 | 0.230 |
Why?
|
| Treatment Outcome | 2 | 2019 | 1259 | 0.200 |
Why?
|
| Overweight | 2 | 2014 | 272 | 0.200 |
Why?
|
| Logistic Models | 4 | 2008 | 953 | 0.190 |
Why?
|
| Sex Factors | 4 | 2013 | 634 | 0.170 |
Why?
|
| SEER Program | 3 | 2004 | 100 | 0.170 |
Why?
|
| Mental Health | 1 | 2021 | 166 | 0.170 |
Why?
|
| Retrospective Studies | 2 | 2024 | 2498 | 0.170 |
Why?
|
| HIV Infections | 1 | 2005 | 682 | 0.170 |
Why?
|
| Meditation | 1 | 2019 | 20 | 0.170 |
Why?
|
| Hispanic Americans | 4 | 2021 | 431 | 0.160 |
Why?
|
| Adaptation, Psychological | 1 | 2019 | 82 | 0.160 |
Why?
|
| Helicobacter Infections | 2 | 2008 | 22 | 0.160 |
Why?
|
| Helicobacter pylori | 2 | 2008 | 24 | 0.160 |
Why?
|
| Pilot Projects | 2 | 2011 | 235 | 0.150 |
Why?
|
| United States | 5 | 2016 | 4119 | 0.150 |
Why?
|
| European Continental Ancestry Group | 5 | 2021 | 559 | 0.150 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 454 | 0.140 |
Why?
|
| Social Support | 1 | 2018 | 211 | 0.140 |
Why?
|
| Telemedicine | 1 | 2019 | 187 | 0.130 |
Why?
|
| Medication Adherence | 1 | 2018 | 255 | 0.130 |
Why?
|
| Citrus | 1 | 2014 | 3 | 0.120 |
Why?
|
| Lycopersicon esculentum | 1 | 2014 | 4 | 0.120 |
Why?
|
| Tea | 1 | 2014 | 8 | 0.120 |
Why?
|
| Diet, High-Fat | 1 | 2014 | 6 | 0.120 |
Why?
|
| Delivery of Health Care | 1 | 2019 | 445 | 0.120 |
Why?
|
| Carbonated Beverages | 1 | 2014 | 14 | 0.120 |
Why?
|
| Diet, Fat-Restricted | 1 | 2014 | 36 | 0.120 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2014 | 12 | 0.120 |
Why?
|
| Hepatitis B virus | 1 | 2014 | 21 | 0.120 |
Why?
|
| Adipose Tissue | 1 | 2014 | 59 | 0.120 |
Why?
|
| Perinatal Care | 1 | 2014 | 12 | 0.120 |
Why?
|
| Viral Load | 1 | 2014 | 132 | 0.120 |
Why?
|
| Anticarcinogenic Agents | 1 | 2013 | 14 | 0.110 |
Why?
|
| Risk | 1 | 2014 | 552 | 0.110 |
Why?
|
| Odds Ratio | 3 | 2008 | 692 | 0.110 |
Why?
|
| Blood Glucose | 1 | 2014 | 344 | 0.110 |
Why?
|
| Esophagoscopy | 2 | 2009 | 19 | 0.100 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2018 | 552 | 0.100 |
Why?
|
| Iron | 2 | 2008 | 17 | 0.100 |
Why?
|
| Socioeconomic Factors | 2 | 2018 | 667 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 643 | 0.100 |
Why?
|
| Confounding Factors (Epidemiology) | 2 | 2008 | 97 | 0.100 |
Why?
|
| Confidence Intervals | 2 | 2008 | 249 | 0.100 |
Why?
|
| Medically Underserved Area | 1 | 2011 | 17 | 0.100 |
Why?
|
| Reproducibility of Results | 2 | 2009 | 394 | 0.100 |
Why?
|
| Histamine H2 Antagonists | 1 | 2010 | 13 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 1023 | 0.090 |
Why?
|
| Ethnic Groups | 2 | 2011 | 504 | 0.090 |
Why?
|
| Proton Pump Inhibitors | 1 | 2010 | 25 | 0.090 |
Why?
|
| Hip Fractures | 1 | 2010 | 70 | 0.090 |
Why?
|
| Disease Progression | 1 | 2010 | 255 | 0.090 |
Why?
|
| Trans Fatty Acids | 1 | 2009 | 4 | 0.080 |
Why?
|
| Cooking | 1 | 2009 | 16 | 0.080 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2009 | 22 | 0.080 |
Why?
|
| Aged, 80 and over | 3 | 2010 | 1956 | 0.080 |
Why?
|
| Ferritins | 1 | 2008 | 10 | 0.080 |
Why?
|
| Geography | 1 | 2008 | 38 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 742 | 0.080 |
Why?
|
| beta Carotene | 1 | 2008 | 18 | 0.080 |
Why?
|
| Vitamin E | 1 | 2008 | 20 | 0.080 |
Why?
|
| Ascorbic Acid | 1 | 2008 | 18 | 0.080 |
Why?
|
| Hemochromatosis | 1 | 2008 | 9 | 0.080 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2008 | 8 | 0.080 |
Why?
|
| Animals | 1 | 2009 | 250 | 0.080 |
Why?
|
| Principal Component Analysis | 1 | 2008 | 23 | 0.080 |
Why?
|
| Risk Assessment | 3 | 2007 | 1137 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2008 | 40 | 0.080 |
Why?
|
| Mutation | 1 | 2008 | 129 | 0.080 |
Why?
|
| Interviews as Topic | 1 | 2008 | 327 | 0.080 |
Why?
|
| Abdominal Fat | 1 | 2007 | 15 | 0.070 |
Why?
|
| Databases, Factual | 1 | 2008 | 330 | 0.070 |
Why?
|
| Central America | 1 | 2005 | 6 | 0.070 |
Why?
|
| Mexico | 1 | 2005 | 21 | 0.070 |
Why?
|
| Condoms | 1 | 2005 | 32 | 0.070 |
Why?
|
| Intracranial Hemorrhages | 1 | 2005 | 16 | 0.060 |
Why?
|
| Health Surveys | 1 | 2005 | 266 | 0.060 |
Why?
|
| Sexual Behavior | 1 | 2005 | 123 | 0.060 |
Why?
|
| Asian Americans | 1 | 2005 | 184 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 318 | 0.060 |
Why?
|
| Personality | 1 | 2003 | 9 | 0.060 |
Why?
|
| Health Behavior | 1 | 2005 | 379 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2005 | 393 | 0.050 |
Why?
|
| Stroke | 1 | 2005 | 306 | 0.050 |
Why?
|
| Asian Continental Ancestry Group | 2 | 2016 | 92 | 0.050 |
Why?
|
| Alcoholism | 1 | 2005 | 346 | 0.050 |
Why?
|
| African Continental Ancestry Group | 2 | 2016 | 165 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 595 | 0.050 |
Why?
|
| Health Status | 1 | 2003 | 331 | 0.050 |
Why?
|
| Substance-Related Disorders | 1 | 2005 | 439 | 0.050 |
Why?
|
| Puerto Rico | 1 | 2020 | 5 | 0.050 |
Why?
|
| New York | 1 | 2020 | 21 | 0.050 |
Why?
|
| Child Abuse | 1 | 2020 | 43 | 0.040 |
Why?
|
| Receptors, Progesterone | 1 | 2018 | 51 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2018 | 70 | 0.040 |
Why?
|
| Public Health Surveillance | 1 | 2018 | 45 | 0.040 |
Why?
|
| Receptors, Estrogen | 1 | 2018 | 56 | 0.040 |
Why?
|
| Focus Groups | 1 | 2018 | 152 | 0.040 |
Why?
|
| Bias | 2 | 2008 | 109 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 147 | 0.040 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 65 | 0.040 |
Why?
|
| Abdomen | 2 | 2008 | 20 | 0.040 |
Why?
|
| Parents | 1 | 2020 | 308 | 0.040 |
Why?
|
| Disease Management | 1 | 2018 | 143 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2018 | 144 | 0.040 |
Why?
|
| Comorbidity | 1 | 2018 | 618 | 0.030 |
Why?
|
| Linear Models | 1 | 2016 | 240 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 351 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 1255 | 0.030 |
Why?
|
| Exercise | 1 | 2016 | 478 | 0.020 |
Why?
|
| Gastric Acid | 1 | 2010 | 4 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 129 | 0.020 |
Why?
|
| Systematized Nomenclature of Medicine | 1 | 2009 | 5 | 0.020 |
Why?
|
| Metaplasia | 1 | 2009 | 7 | 0.020 |
Why?
|
| Observer Variation | 1 | 2009 | 39 | 0.020 |
Why?
|
| Esophagus | 1 | 2009 | 12 | 0.020 |
Why?
|
| Medical Audit | 1 | 2009 | 40 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2009 | 28 | 0.020 |
Why?
|
| Iron, Dietary | 1 | 2008 | 7 | 0.020 |
Why?
|
| Biopsy | 1 | 2009 | 73 | 0.020 |
Why?
|
| Hemochromatosis Protein | 1 | 2008 | 8 | 0.020 |
Why?
|
| Homozygote | 1 | 2008 | 14 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2009 | 87 | 0.020 |
Why?
|
| Heterozygote | 1 | 2008 | 29 | 0.020 |
Why?
|
| Effect Modifier, Epidemiologic | 1 | 2008 | 8 | 0.020 |
Why?
|
| Antigens, Bacterial | 1 | 2007 | 8 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2007 | 17 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 2007 | 37 | 0.020 |
Why?
|
| Thigh | 1 | 2007 | 11 | 0.020 |
Why?
|
| Waist-Hip Ratio | 1 | 2007 | 23 | 0.020 |
Why?
|
| Education, Medical, Continuing | 1 | 2007 | 31 | 0.020 |
Why?
|
| Anthropometry | 1 | 2006 | 63 | 0.020 |
Why?
|
| Age Distribution | 1 | 2006 | 257 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 407 | 0.020 |
Why?
|
| Prevalence | 1 | 2008 | 892 | 0.020 |
Why?
|
| Time Factors | 1 | 2008 | 1114 | 0.020 |
Why?
|
| African Americans | 1 | 2005 | 485 | 0.010 |
Why?
|
Concepts
(213)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(14)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_
-->